WO2024231722 - METHOD OF PRODUCING AN AUTOPROBIOTIC FORMULATION AND USE THEREOF
National phase entry is expected:
Publication Number
WO/2024/231722
Publication Date
14.11.2024
International Application No.
PCT/IB2023/059333
International Filing Date
21.09.2023
Title **
[English]
METHOD OF PRODUCING AN AUTOPROBIOTIC FORMULATION AND USE THEREOF
[French]
PROCÉDÉ DE PRODUCTION D'UNE FORMULATION AUTOPROBIOTIQUE ET SON UTILISATION
Applicants **
NIKOLAEV, Fedor
Tabenkin Str. 22, Givatayim
5362008 Givatayim, IL
Inventors
SUVOROV, Aleksandr
Embankment Petrovskaya 2 lit.2, apartment 25
Saint-Petersburg 197046, RU
Priority Data
P-202300066
11.05.2023
SI
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Natural Person
* |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1690 | |
| EPO | Filing, Examination | 7260 | |
| Japan | Filing | 531 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 4435 |
Total: 14491 USD
Abstract[English]
The present invention relates to the field of microbiology and personalized medicine and discloses a method for producing a novel personalized autoprobiotic formulation based on indigenous microbiota of a subject, characterized with high safety and efficacy, and personalized according to health state of the subject. The invention further relates to methods for improving the health of the subject using microorganisms indigenous to the subject's gut microbiome.[French]
La présente invention se rapporte au domaine de la microbiologie et de la médecine personnalisée et concerne un procédé de production d'une nouvelle formulation autoprobiotique personnalisée sur la base d'un microbiote indigène d'un sujet, caractérisé par une sécurité et une efficacité élevées, et personnalisé en fonction de l'état de santé du sujet. L'invention concerne en outre des procédés permettant d'améliorer la santé du sujet à l'aide de micro-organismes indigènes au microbiome intestinal du sujet.